COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 56,024 | 1,152,520 | SH | | SOLE | | 1,152,520 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 15 | 213 | SH | | SOLE | | 213 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 11,417 | 231,200 | SH | | SOLE | | 231,200 | 0 | 0 |
Accelerate Diagnostics, Inc. | Common | 00430H102 | 2,735 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 1,813 | 59,654 | SH | | SOLE | | 59,654 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 6,584 | 1,466,368 | SH | | SOLE | | 1,466,368 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 5/15/19 | 00767EAB8 | 10,546 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 2,881 | 1,405,324 | SH | | SOLE | | 1,405,324 | 0 | 0 |
Akorn, Inc. | Common | 009728106 | 10,992 | 327,735 | SH | | SOLE | | 327,735 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 91,363 | 750,905 | SH | | SOLE | | 750,905 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 75,506 | 310,610 | SH | | SOLE | | 310,610 | 0 | 0 |
Allergan plc | Preferred Convertible Series A | G0177J116 | 4,340 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621200 | 611 | 1,650,000 | SH | | SOLE | | 1,650,000 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 604 | 47,300 | SH | | SOLE | | 47,300 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 9,170 | 114,966 | SH | | SOLE | | 114,966 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 24,094 | 254,887 | SH | | SOLE | | 254,887 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 117,947 | 684,824 | SH | | SOLE | | 684,824 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 1,619 | 160,730 | SH | | SOLE | | 160,730 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 1,988 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 3,261 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
Argenx SE | Sponsored ADR | 04016X101 | 1,591 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 18,770 | 550,600 | SH | | SOLE | | 550,600 | 0 | 0 |
Auris Medical Holding AG | Common | H03579101 | 554 | 774,504 | SH | | SOLE | | 774,504 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 6,886 | 624,288 | SH | | SOLE | | 624,288 | 0 | 0 |
Avexis, Inc. | Common | 05366U100 | 822 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 701 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 143,759 | 529,774 | SH | | SOLE | | 529,774 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 45,568 | 501,745 | SH | | SOLE | | 501,745 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 1,394 | 13,273 | SH | | SOLE | | 13,273 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 10,392 | 186,500 | SH | | SOLE | | 186,500 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 5,969 | 76,600 | SH | | SOLE | | 76,600 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 189,169 | 1,456,605 | SH | | SOLE | | 1,456,605 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 261 | 105,800 | SH | | SOLE | | 105,800 | 0 | 0 |
Cellectis S.A. | Sponsored ADR | 15117K103 | 8,011 | 310,250 | SH | | SOLE | | 310,250 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 15,385 | 192,600 | SH | | SOLE | | 192,600 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 12,856 | 127,100 | SH | | SOLE | | 127,100 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 2,149 | 286,472 | SH | | SOLE | | 286,472 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 14,044 | 83,900 | SH | | SOLE | | 83,900 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 14,119 | 150,800 | SH | | SOLE | | 150,800 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 1,292 | 90,000 | SH | | SOLE | | 90,000 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 2,031 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 33,141 | 411,891 | SH | | SOLE | | 411,891 | 0 | 0 |
CytomX Therapeutics, Inc. | Common | 23284F105 | 8,216 | 530,092 | SH | | SOLE | | 530,092 | 0 | 0 |
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,278 | 63,800 | SH | | SOLE | | 63,800 | 0 | 0 |
Dermira, Inc. | Common | 24983L104 | 11,274 | 386,900 | SH | | SOLE | | 386,900 | 0 | 0 |
DexCom, Inc. | Common | 252131107 | 6,181 | 84,500 | SH | | SOLE | | 84,500 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 6,833 | 461,712 | SH | | SOLE | | 461,712 | 0 | 0 |
Dynavax Technologies Corporation | Common | 268158201 | 3,330 | 345,050 | SH | | SOLE | | 345,050 | 0 | 0 |
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 4,454 | 7,000,000 | PRN | | SOLE | | 7,000,000 | 0 | 0 |
Eli Lilly & Company | Common | 532457108 | 40,582 | 493,100 | SH | | SOLE | | 493,100 | 0 | 0 |
Endo International plc | Shares | G30401106 | 10,216 | 914,548 | SH | | SOLE | | 914,548 | 0 | 0 |
Entellus Medical, Inc. | Common | 29363K105 | 5,655 | 341,471 | SH | | SOLE | | 341,471 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 4,243 | 281,000 | SH | | SOLE | | 281,000 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 13,587 | 551,647 | SH | | SOLE | | 551,647 | 0 | 0 |
Express Scripts Holding Company | Common | 30219G108 | 5,394 | 84,500 | SH | | SOLE | | 84,500 | 0 | 0 |
Flex Pharma, Inc. | Common | 33938A105 | 614 | 159,549 | SH | | SOLE | | 159,549 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 4,317 | 930,398 | SH | | SOLE | | 930,398 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 1,454 | 19,000 | SH | | SOLE | | 19,000 | 0 | 0 |
GenMark Diagnostics, Inc. | Common | 372309104 | 1,104 | 93,349 | SH | | SOLE | | 93,349 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 179,083 | 2,530,131 | SH | | SOLE | | 2,530,131 | 0 | 0 |
GlaxoSmithKline plc | Shares | 37733W105 | 15,480 | 359,000 | SH | | SOLE | | 359,000 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 3,419 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 656 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 8,304 | 95,232 | SH | | SOLE | | 95,232 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,454 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 421946104 | 2,322 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,431 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
Horizon Pharma plc | Shares | G4617B105 | 1,934 | 162,900 | SH | | SOLE | | 162,900 | 0 | 0 |
Humana Inc. | Common | 444859102 | 30,025 | 124,781 | SH | | SOLE | | 124,781 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 21,364 | 132,352 | SH | | SOLE | | 132,352 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 48,405 | 278,960 | SH | | SOLE | | 278,960 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 2,002 | 124,335 | SH | | SOLE | | 124,335 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 87,290 | 693,275 | SH | | SOLE | | 693,275 | 0 | 0 |
Innoviva, Inc. | Common | 45781M101 | 3,185 | 248,803 | SH | | SOLE | | 248,803 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 448 | 28,000 | SH | | SOLE | | 28,000 | 0 | 0 |
iShares Nasdaq Biotechnology ETF | Nasdaq Biotech ETF | 464287556 | 23,557 | 75,970 | SH | | SOLE | | 75,970 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 42,594 | 273,916 | SH | | SOLE | | 273,916 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 94,503 | 714,362 | SH | | SOLE | | 714,362 | 0 | 0 |
Juno Therapeutics, Inc. | Common | 48205A109 | 1,701 | 56,900 | SH | | SOLE | | 56,900 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 6,848 | 756,679 | SH | | SOLE | | 756,679 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 7,000 | 136,212 | SH | | SOLE | | 136,212 | 0 | 0 |
Mallinckrodt plc | Shares | G5785G107 | 2,774 | 61,900 | SH | | SOLE | | 61,900 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 23,496 | 142,800 | SH | | SOLE | | 142,800 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 12,969 | 1,007,717 | SH | | SOLE | | 1,007,717 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 51,504 | 580,326 | SH | | SOLE | | 580,326 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 94,423 | 1,473,295 | SH | | SOLE | | 1,473,295 | 0 | 0 |
Merus B.V. | Common | N5749R100 | 7,595 | 479,150 | SH | | SOLE | | 479,150 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,584 | 152,900 | SH | | SOLE | | 152,900 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 62,233 | 1,603,112 | SH | | SOLE | | 1,603,112 | 0 | 0 |
Myovant Sciences Ltd. | Common | G637AM102 | 4,680 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Nabriva Therapeutics plc | Shares | G63637105 | 1,677 | 149,334 | SH | | SOLE | | 149,334 | 0 | 0 |
NanoString Technologies, Inc. | Common | 63009R109 | 1,877 | 113,500 | SH | | SOLE | | 113,500 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 5,275 | 485,758 | SH | | SOLE | | 485,758 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 25,873 | 562,467 | SH | | SOLE | | 562,467 | 0 | 0 |
Nevro Corp. | Common | 64157F103 | 14,486 | 194,621 | SH | | SOLE | | 194,621 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 5,708 | 567,997 | SH | | SOLE | | 567,997 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 33,276 | 398,662 | SH | | SOLE | | 398,662 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 657 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 9,320 | 217,300 | SH | | SOLE | | 217,300 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 15,144 | 458,616 | SH | | SOLE | | 458,616 | 0 | 0 |
Ovid Therapeutics Inc. | Common | 690469101 | 5,229 | 535,824 | SH | | SOLE | | 535,824 | 0 | 0 |
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 12,845 | 533,000 | SH | | SOLE | | 533,000 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 2,817 | 37,300 | SH | | SOLE | | 37,300 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 27,211 | 810,087 | SH | | SOLE | | 810,087 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 10,688 | 530,672 | SH | | SOLE | | 530,672 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 14,358 | 2,837,573 | SH | | SOLE | | 2,837,573 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 7,651 | 102,000 | SH | | SOLE | | 102,000 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 17,702 | 202,537 | SH | | SOLE | | 202,537 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 98 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 7,418 | 395,818 | SH | | SOLE | | 395,818 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 92,170 | 187,666 | SH | | SOLE | | 187,666 | 0 | 0 |
Retrophin, Inc. | Common | 761299106 | 3,257 | 167,949 | SH | | SOLE | | 167,949 | 0 | 0 |
The RMR Group Inc. | Class A | 74967R106 | 362 | 7,441 | SH | | SOLE | | 7,441 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 13,279 | 550,990 | SH | | SOLE | | 550,990 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 7,206 | 90,480 | SH | | SOLE | | 90,480 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 8,619 | 179,900 | SH | | SOLE | | 179,900 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 17,246 | 511,600 | SH | | SOLE | | 511,600 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 11,574 | 223,700 | SH | | SOLE | | 223,700 | 0 | 0 |
Senior Housing Properties Trust | Shares | 81721M109 | 13,216 | 646,554 | SH | | SOLE | | 646,554 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 41,667 | 252,113 | SH | | SOLE | | 252,113 | 0 | 0 |
Spark Therapeutics, Inc. | Common | 84652J103 | 1,452 | 24,300 | SH | | SOLE | | 24,300 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 17,478 | 226,460 | SH | | SOLE | | 226,460 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,794 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 6,062 | 313,440 | SH | | SOLE | | 313,440 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 7,161 | 1,004,322 | SH | | SOLE | | 1,004,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 33,743 | 1,015,758 | SH | | SOLE | | 1,015,758 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 24,272 | 139,120 | SH | | SOLE | | 139,120 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 1,980 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 7,907 | 127,308 | SH | | SOLE | | 127,308 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 1,492 | 241,021 | SH | | SOLE | | 241,021 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 5,703 | 43,961 | SH | | SOLE | | 43,961 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 57,012 | 307,476 | SH | | SOLE | | 307,476 | 0 | 0 |
Universal Health Services, Inc. | Class B | 913903100 | 5,869 | 48,076 | SH | | SOLE | | 48,076 | 0 | 0 |
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 7,439 | 430,000 | SH | | SOLE | | 430,000 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 12,228 | 175,991 | SH | | SOLE | | 175,991 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 3,211 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 102,845 | 798,053 | SH | | SOLE | | 798,053 | 0 | 0 |
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 13,252 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 1,602 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 5,904 | 214,781 | SH | | SOLE | | 214,781 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 422 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,103 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
Zafgen, Inc. | Common | 98885E103 | 47 | 13,307 | SH | | SOLE | | 13,307 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 13,135 | 102,300 | SH | | SOLE | | 102,300 | 0 | 0 |